Inventor · disambiguated record
Hiroyasu Toyota
Also filed as: TOYOTA HIROYASU
4 granted patents·9 pending applications·2 citations·filing 2013–2024
66Inventor score
Files withASTELLAS PHARMA INC6BEND RES3BEND RES INC2AMBIT BIOSCIENCES CORP1MEDIVATION PROSTATE THERAPEUTICS LLC1
Top patents by PatentIndex Score
13 records- 0192US11839689B2Formulations of enzalutamideASTELLAS PHARMA INC·Filed 2022·Granted Dec 12, 2023·2 cites·7 claims
- 0289US12502357B2Formulations of enzalutamideASTELLAS PHARMA INC·Filed 2024·Granted Dec 23, 2025·0 cites·1 claims
- 0387US2025049721A1Formulations of EnzalutamideASTELLAS PHARMA INC·Filed 2024·Application pending·0 cites
- 0482US12447128B2Formulations of enzalutamideASTELLAS PHARMA INC·Filed 2022·Granted Oct 21, 2025·0 cites·4 claims
- 0567US2020060976A1Formulations of enzalutamideASTELLAS PHARMA INC·Filed 2019·Application pending·0 cites
- 0664US2019209476A1Formulations of enzalutamideMEDIVATION PROSTATE THERAPEUTICS LLC·Filed 2018·Application pending·0 cites
- 0762US2014378517A1Formulations of enzalutamideBEND RES·Filed 2014·Application pending·0 cites
- 0860US2017224624A1Formulations of enzalutamideBEND RES INC·Filed 2016·Application pending·0 cites
- 0959US2014179749A1Formulations of enzalutamideBEND RES·Filed 2013·Application pending·0 cites
- 1059US2014100256A1Formulations of enzalutamideBEND RES·Filed 2013·Application pending·0 cites
- 1158US2017027910A1Formulations of enzalutamideBEND RES INC·Filed 2016·Application pending·0 cites
- 1245US2015306090A1Orally administered medical compositionASTELLAS PHARMA INC·Filed 2013·Application pending·0 cites
- 1342US9675549B2Tablet containing composite with cyclodextrinAMBIT BIOSCIENCES CORP·Filed 2013·Granted Jun 13, 2017·0 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when Hiroyasu Toyota files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →